C.R. Franks

1.2k total citations
51 papers, 672 citations indexed

About

C.R. Franks is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, C.R. Franks has authored 51 papers receiving a total of 672 indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Oncology, 23 papers in Immunology and 7 papers in Molecular Biology. Recurrent topics in C.R. Franks's work include Immunotherapy and Immune Responses (14 papers), Immune Cell Function and Interaction (12 papers) and Cancer Immunotherapy and Biomarkers (9 papers). C.R. Franks is often cited by papers focused on Immunotherapy and Immune Responses (14 papers), Immune Cell Function and Interaction (12 papers) and Cancer Immunotherapy and Biomarkers (9 papers). C.R. Franks collaborates with scholars based in United Kingdom, France and Netherlands. C.R. Franks's co-authors include F. T. Perkins, Peter Palmer, G. Stoter, Oleg Eremin, S.H. Goey, R. Oskam, R. L. H. Bolhuis, Yvonne Williams, Rob L. H. Jansen and W. G. Spector and has published in prestigious journals such as Nature, The Lancet and JAMA.

In The Last Decade

C.R. Franks

51 papers receiving 624 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
C.R. Franks United Kingdom 17 302 293 110 90 88 51 672
Oldham Rk United States 14 264 0.9× 157 0.5× 89 0.8× 20 0.2× 102 1.2× 37 596
K Takatsuki Japan 13 148 0.5× 269 0.9× 181 1.6× 183 2.0× 103 1.2× 40 756
Alexia Buzzonetti Italy 14 231 0.8× 280 1.0× 116 1.1× 45 0.5× 30 0.3× 30 615
P. Gjörstrup Sweden 10 187 0.6× 293 1.0× 179 1.6× 121 1.3× 45 0.5× 15 912
B. G. Leventhal United States 10 156 0.5× 113 0.4× 110 1.0× 142 1.6× 89 1.0× 12 594
Eleonora Baldi Italy 15 312 1.0× 265 0.9× 145 1.3× 50 0.6× 90 1.0× 36 853
Noriaki Tokuda Japan 16 125 0.4× 199 0.7× 203 1.8× 80 0.9× 279 3.2× 60 798
B M Colls New Zealand 13 137 0.5× 78 0.3× 146 1.3× 61 0.7× 136 1.5× 28 537
Hiral Patel United States 13 194 0.6× 310 1.1× 126 1.1× 45 0.5× 61 0.7× 22 647
Agata Kosmaczewska Poland 19 245 0.8× 499 1.7× 100 0.9× 61 0.7× 32 0.4× 49 785

Countries citing papers authored by C.R. Franks

Since Specialization
Citations

This map shows the geographic impact of C.R. Franks's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C.R. Franks with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C.R. Franks more than expected).

Fields of papers citing papers by C.R. Franks

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C.R. Franks. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C.R. Franks. The network helps show where C.R. Franks may publish in the future.

Co-authorship network of co-authors of C.R. Franks

This figure shows the co-authorship network connecting the top 25 collaborators of C.R. Franks. A scholar is included among the top collaborators of C.R. Franks based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C.R. Franks. C.R. Franks is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Virji‐Babul, Naznin, et al.. (2014). Changes in Functional Brain Networks following Sports-Related Concussion in Adolescents. Journal of Neurotrauma. 31(23). 1914–1919. 45 indexed citations
2.
Heys, S, Oleg Eremin, Enzo Maria Ruggeri, et al.. (1995). A phase III study of recombinant interleukin-2, 5-fluorouracil and leucovorin versus 5-fluorouracil and leucovorin in patients with unresectable or metastatic colorectal carcinoma. European Journal of Cancer. 31(1). 19–25. 12 indexed citations
3.
Broom, J., et al.. (1994). In vivo cytokine production and recombinant interleukin 2 immunotherapy: an insight into the possible mechanisms underlying clinical responses. British Journal of Cancer. 69(6). 1130–1135. 23 indexed citations
4.
Stam, Anita G.M., B. Mary E. von Blomberg, Gerda Roest, et al.. (1994). The development of anti-interleukin-2 (IL-2) antibodies in cancer patients treated with recombinant IL-2. European Journal of Cancer. 30(12). 1804–1809. 17 indexed citations
5.
Palmer, Peter, B. Mary E. von Blomberg, Anita G.M. Stam, et al.. (1994). Persistent augmentation of natural-killer-and T-cell-mediated cytotoxicity in peripheral blood mononuclear cells pulsed in vitro with high-dose recombinant interleukin-2 prior to culturing with a low maintenance dose. Cancer Immunology Immunotherapy. 39(1). 34–40. 2 indexed citations
6.
Khayat, D., E Antoine, Olivier Rixe, et al.. (1993). Chemoimmunotherapy of metastatic malignant melanoma The Salpétrière Hospital (SOMPS) experiences. European Journal of Cancer. 29. S2–S5. 6 indexed citations
7.
Palmer, Peter, A. Mercatello, Patrice Viens, et al.. (1992). Phase I Trial of Recombinant Interleukin-2 Followed by Recombinant Tumor Necrosis Factor in Patients with Metastatic Cancer. Journal of Immunotherapy. 11(2). 93–102. 14 indexed citations
8.
Kirchner, Hartmut, Pauline Evers, Márta Szamel, et al.. (1991). The development of neutralizing antibodies in a patient receiving subcutaneous recombinant and natural interleukin-2. Cancer. 67(7). 1862–1864. 20 indexed citations
9.
Lévy, Vincent, et al.. (1991). Interleukin-2 therapy for refractory and relapsing lymphomas. European Journal of Cancer and Clinical Oncology. 27(12). 1676–1680. 12 indexed citations
10.
Favrot, M, Jean Michon, D. Floret, et al.. (1990). Interleukin 2 Immunotherapy in Children with Neuroblastoma after High-Dose Chemotherapy and Autologous Bone Marrow Transplantation. Pediatric Hematology and Oncology. 7(3). 275–284. 11 indexed citations
11.
Macdonald, Donald, Premini Mahendra, R. Oskam, et al.. (1990). Recombinant interleukin 2 for acute myeloid leukaemia in first complete remission: A pilot study. Leukemia Research. 14(11-12). 967–973. 29 indexed citations
12.
Atzpodien, Jens, et al.. (1990). Treatment of metastatic renal cell cancer patients with recombinant subcutaneous human interleukin-2 and interferon-α. Annals of Oncology. 1(5). 377–378. 15 indexed citations
13.
Favrot, M, D. Floret, Jean Michon, et al.. (1989). A phase-II study of adoptive immunotherapy with continuous infusion of interleukin-2 in children with advanced neuroblastoma. A report on 11 cases. Cancer Treatment Reviews. 16. 129–142. 18 indexed citations
14.
Panici, P. Benedetti, Giovanni Scambia, Stefano Greggi, et al.. (1989). Recombinant interleukin-2 continuous infusion in ovarian cancer patients with minimal residual disease at second-look. Cancer Treatment Reviews. 16. 123–127. 4 indexed citations
15.
Philip, Thierry, A. Mercatello, Sylvie Négrier, et al.. (1989). Interleukin-2 with and without LAK cells in metastatic renal cell carcinoma: the Lyon first-year experience in 20 patients. Cancer Treatment Reviews. 16. 91–104. 22 indexed citations
16.
Israël, Lucien, et al.. (1989). Some theoretical and practical limitations of interleukin-2. ten cases of advanced breast cancer treated with continuous infusion of IL-2. Cancer Treatment Reviews. 16. 169–171. 8 indexed citations
17.
Lindemann, A., Klaus Hoeffken, Reinhold E. Schmidt, et al.. (1989). A multicenter trial of interleukin-2 and low-dose cyclophosphamide in highly chemotherapy-resistant malignancies. Cancer Treatment Reviews. 16. 53–57. 18 indexed citations
18.
Hamblin, Terry J., Freda K. Stevenson, Peter Williamson, et al.. (1989). A phase-II trial of recombinant interleukin-2 and 5-FU chemotherapy in patients with metastatic colorectal carcinoma. Cancer Treatment Reviews. 16. 163–167. 14 indexed citations
19.
Stoter, G., Eitan Shiloni, S. Gundersen, et al.. (1989). Alternating recombinant human interleukin-2 and dacarbazine in advanced melanoma. A multicentric phase II study. Cancer Treatment Reviews. 16. 59–63. 10 indexed citations
20.
Franks, C.R., et al.. (1975). The effect of sex hormones on the growth of HeLa tumour nodules in male and female mice. British Journal of Cancer. 31(1). 100–110. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Oldham Rk Breakdown of academic impact, for papers by K Takatsuki Breakdown of academic impact, for papers by Alexia Buzzonetti Breakdown of academic impact, for papers by P. Gjörstrup Breakdown of academic impact, for papers by B. G. Leventhal Breakdown of academic impact, for papers by Eleonora Baldi Breakdown of academic impact, for papers by Noriaki Tokuda Breakdown of academic impact, for papers by B M Colls Breakdown of academic impact, for papers by Hiral Patel Breakdown of academic impact, for papers by Agata Kosmaczewska
Rankless by CCL
2026